Stock Ticker

  • Loading stock data...

Market Watch-List: IMS Health Holdings Inc (NYSE:IMS), Ampio Pharmaceuticals Inc (NYSEMKT:AMPE), Xunlei Ltd (NASDAQ:XNET)

Boston, MA 06/26/2014 (wallstreetpr) – IMS Health Holdings Inc (NYSE:IMS) will spend about $520 million in cash to purchase divisions of software developer Cegedim. The company develops software for the healthcare industry. The acquisition involves takeover of Cegedim’s CRM solutions, which help users to achieve sales efficiencies and reduce regulatory compliance challenges. The acquisition will mark the second purchase by IMS Health Holdings Inc (NYSE:IMS) since its IPO in April during which nearly $1.4 billion was raised. Last month the company acquired Forcea, which is a Belgian company that provides business intelligence solutions.

The $1.4 billion IPO of IMS Health Holdings Inc (NYSE:IMS) stands as the second biggest in the U.S. so far in 2014.

Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has notified FDA’s Transplant and Ophthalmology Division of its plans to reduce the size of its study sample for OptimEyes Study, which is targeted for the treatment of Diabetic Macular Edema. The company said the trial was originally intended to enroll 450 patients and powered at 95 percent. However, with enrollment of more than 355 patients that provide power of 88 percent, Ampio believes the size is more than enough for statistical evaluation.

The request to lower the patient enrollment size for OptimEyes Study comes at a time when the company is gaining favorable coverage in Wall Street. Analysts at Aegis moved to issue a Buy rating on the stock on Wednesday. The positive rating from Aegis came hot on the heels of a Buy rating from Citigroup Inc (NYSE:C), which also issued a Buy rating on the stock.

Xunlei Ltd (NASDAQ:XNET) soared on NASDAQ on debut trading, raising confidence on the stock. Shares of the company gained more than 2.4 percent to $15.26 Wednesday, a day after the initial public offering of the stock at $12 apiece. About 7.3 million shares were offered in the IPO, which was priced in the range of $9 – $11 per share. The offering ended up raising almost $88 million for the company. Xunlei Ltd (NASDAQ:XNET) is a provider of digital media.

Published by Nicholas Maithya

Nicholas is a Financial Analyst by profession, who enjoys writing about investments, technological developments, business, economics and other financial topics at various financial publications. Join him here on Wallstreetpr.com as he endeavors to deliver to you the latest breaking news on the above mentioned fronts. Contact him by email at [email protected] or follow Nicholas Kitonyi @nmaithyak on Twitter.



Recent Stories

SignUp Now For Our Featured Newsletter